139 related articles for article (PubMed ID: 31874173)
1. Integrated metabolomic analysis for intervention effects of Gushudan on glucocorticoid-induced osteoporostic rat plasma based on RP/HILIC-UHPLC-Q-Orbitrap HRMS.
Yuan X; Wen J; Jia H; Tong L; Zhao J; Zhao L; Xiong Z
Anal Biochem; 2020 Feb; 591():113559. PubMed ID: 31874173
[TBL] [Abstract][Full Text] [Related]
2.
Liu S; Yuan X; Ma C; Zhao J; Xiong Z
Anal Biochem; 2020 Dec; 610():113992. PubMed ID: 33075315
[TBL] [Abstract][Full Text] [Related]
3. An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats.
Huang Y; Bo Y; Wu X; Wang Q; Qin F; Zhao L; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():119-30. PubMed ID: 27281385
[TBL] [Abstract][Full Text] [Related]
4. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024
[TBL] [Abstract][Full Text] [Related]
5. Integrated UHPLC-MS untargeted metabolomics and gut microbe metabolism pathway-targeted metabolomics to reveal the prevention mechanism of Gushudan on kidney-yang-deficiency-syndrome rats.
Xin L; Ren M; Lou Y; Yin H; Qin F; Xiong Z
J Pharm Biomed Anal; 2024 May; 242():116062. PubMed ID: 38387127
[TBL] [Abstract][Full Text] [Related]
6. An integrated fecal metabolomic based on
Xin L; Liu S; Lou Y; Zhang J; Lu Q; Zhao L; Wei X; Xiong Z
Biomed Chromatogr; 2023 Sep; 37(9):e5693. PubMed ID: 37403411
[TBL] [Abstract][Full Text] [Related]
7. Integrated renal metabolomic and metallomic profiling revealed protective effect and metabolic mechanism of Gushudan on glucocorticoid-induced osteoporotic rat based on GC-MS and ICP-MS.
Jia H; Yuan X; Liu S; Feng Q; Zhao J; Zhao L; Xiong Z
J Pharm Biomed Anal; 2021 Jan; 193():113705. PubMed ID: 33188945
[TBL] [Abstract][Full Text] [Related]
8. Profiling the metabolome changes caused by cranberry procyanidins in plasma of female rats using (1) H NMR and UHPLC-Q-Orbitrap-HRMS global metabolomics approaches.
Liu H; Garrett TJ; Tayyari F; Gu L
Mol Nutr Food Res; 2015 Nov; 59(11):2107-18. PubMed ID: 26264887
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics and serum pharmacochemistry revealed the preventive mechanism of Gushudan in kidney-yang-deficiency-syndrome rats.
Lu Q; Feng Q; Yu J; Tong L; Zhang J; Sun J; Zhao J; Xiong Z
Biomed Chromatogr; 2023 Mar; 37(3):e5569. PubMed ID: 36527197
[TBL] [Abstract][Full Text] [Related]
10. Integrated serum pharmacochemistry, network pharmacology and pharmacokinetics to explore bioactive components of Gushudan in the treatment of osteoporosis.
Ren L; Li Q; Zhang L; Wang R; Qin F; Zhao L; Wei X; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123762. PubMed ID: 37247535
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics approach in lung tissue of septic rats and the interventional effects of Xuebijing injection using UHPLC-Q-Orbitrap-HRMS.
Xu T; Zhou L; Shi Y; Liu L; Zuo L; Jia Q; Du S; Kang J; Zhang X; Sun Z
J Biochem; 2018 Dec; 164(6):427-435. PubMed ID: 30165618
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis.
Xia T; Dong X; Lin L; Jiang Y; Ma X; Xin H; Zhang Q; Qin L
J Pharm Biomed Anal; 2019 Mar; 166():336-346. PubMed ID: 30690247
[TBL] [Abstract][Full Text] [Related]
13. Integrative serum metabolomic analysis for preventive effects of Yaobitong capsule in adjuvant-induced rheumatoid arthritis rat based on RP/HILIC-UHPLC-Q-TOF MS.
Shi W; Deng Y; Zhao C; Xiao W; Wang Z; Xiong Z; Zhao L
Anal Biochem; 2022 Jan; 637():114474. PubMed ID: 34801482
[TBL] [Abstract][Full Text] [Related]
14. UHPLC-Q-Orbitrap-HRMS-based global metabolomics reveal metabolome modifications in plasma of young women after cranberry juice consumption.
Liu H; Garrett TJ; Su Z; Khoo C; Gu L
J Nutr Biochem; 2017 Jul; 45():67-76. PubMed ID: 28433923
[TBL] [Abstract][Full Text] [Related]
15. Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.
Huang Y; Liu X; Zhao L; Li F; Xiong Z
Biomed Chromatogr; 2014 Jun; 28(6):878-84. PubMed ID: 24861758
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, bioavailability, excretion, and metabolic analysis of Schisanlactone E, a bioactive ingredient from Kadsura heteroclita (Roxb) Craib, in rats by UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS.
Liu R; Liu Q; Li B; Liu L; Cheng D; Cai X; Liu W; Wang W
J Pharm Biomed Anal; 2020 Jan; 177():112875. PubMed ID: 31546138
[TBL] [Abstract][Full Text] [Related]
17. Antiseptic Activity of Ethnomedicinal Xuebijing Revealed by the Metabolomics Analysis Using UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhou L; Xu T; Li Z; Liu L; Shi Y; Kang J; Gao G; Du S; Sun Z; Zhang X
Front Pharmacol; 2018; 9():300. PubMed ID: 29651245
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhong Q; Wang Z; Sun Z; Zhou L; Li Z; Xu T; Shi Y; Tang J; Du S; Zhang X
J Pharm Biomed Anal; 2017 Nov; 146():347-353. PubMed ID: 28918324
[TBL] [Abstract][Full Text] [Related]
19.
Feng Q; Tong L; Lu Q; Liu S; Zhao L; Xiong Z
Anal Biochem; 2022 Apr; 643():114580. PubMed ID: 35149001
[TBL] [Abstract][Full Text] [Related]
20. UHPLC-LTQ-Orbitrap MS combined with spike-in method for plasma metabonomics analysis of acute myocardial ischemia rats and pretreatment effect of Danqi Tongmai tablet.
Yan B; Deng Y; Hou J; Bi Q; Yang M; Jiang B; Liu X; Wu W; Guo D
Mol Biosyst; 2015 Feb; 11(2):486-96. PubMed ID: 25418780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
